Autopsy report · NCT02362984

DLBS1033 for the Treatment of Acute Ischemic Stroke

“Major technical hindrance in recruitment.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 months after it had already started.
• Ran for about 2 years 6 months before it stopped.
• 9 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Dexa Medica Group

Sponsor type

Industry

Conditions

Acute Ischemic Stroke

Interventions

Placebo; DLBS1033

Participants

9

Sites

1

Countries

Indonesia

Trials that died the same way

• Ospemifene vs. Conjugated Estrogens in the Treatment of Postmenopausal Sexual Dysfunction
  “Obstacles with recruitment” (81% match in meaning)
• Efficacy of Angiographic Embolization vs Non-embolization of Moderate/Poor Vascularized Vertebral Metastases on Intraoperative Bleeding During Surgery Decompression and Vertebral Stabilization.
  “Difficulties in recruitment.” (78% match in meaning)
• The Cirrhosis Outpatient Optimization, Readmission & Safety Study
  “Increased recruitment difficulties” (78% match in meaning)
• Alzheimer Disease : Rehabilitation's Intervention at Home
  “difficulties of recruitment” (78% match in meaning)
• Paracetamol and Neuropathic Pain
  “Recruitment difficulties” (77% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.